# Helicobacter Pylori Treatment in Immune Thrombocytopenic Purpura (ITP) Patients

> **NCT01730352** · PHASE2,PHASE3 · COMPLETED · sponsor: **Federal University of São Paulo** · enrollment: 100 (actual)

## Conditions studied

- Immune Thrombocytopenic Purpura
- Helicobacter Pylori Infection

## Interventions

- **DRUG:** H. pylori triple therapy

## Key facts

- **NCT ID:** NCT01730352
- **Lead sponsor:** Federal University of São Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2011-05
- **Final completion:** 2012-03
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2012-11-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01730352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01730352, "Helicobacter Pylori Treatment in Immune Thrombocytopenic Purpura (ITP) Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01730352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*